Kwang Dong Pharmaceutical Statistics

Total Valuation

Kwang Dong Pharmaceutical has a market cap or net worth of KRW 228.46 billion. The enterprise value is 345.56 billion.

Market Cap	228.46B
Enterprise Value	345.56B

Important Dates

The next estimated earnings date is Tuesday, March 18, 2025.

Earnings Date	Mar 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Kwang Dong Pharmaceutical has 40.08 million shares outstanding. The number of shares has decreased by -1.58% in one year.

Current Share Class	n/a
Shares Outstanding	40.08M
Shares Change (YoY)	-1.58%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	12.69%
Owned by Institutions (%)	26.49%
Float	33.04M

Valuation Ratios

The trailing PE ratio is 6.75.

PE Ratio	6.75
Forward PE	n/a
PS Ratio	0.14
PB Ratio	0.40
P/TBV Ratio	0.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.70, with an EV/FCF ratio of -4.54.

EV / Earnings	10.20
EV / Sales	0.21
EV / EBITDA	8.70
EV / EBIT	13.23
EV / FCF	-4.54

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.47.

Current Ratio	1.41
Quick Ratio	0.97
Debt / Equity	0.47
Debt / EBITDA	7.26
Debt / FCF	-3.84
Interest Coverage	2.85

Financial Efficiency

Return on equity (ROE) is 5.91% and return on invested capital (ROIC) is 2.00%.

Return on Equity (ROE)	5.91%
Return on Assets (ROA)	1.52%
Return on Capital (ROIC)	2.00%
Revenue Per Employee	1.57B
Profits Per Employee	32.51M
Employee Count	1,042
Asset Turnover	1.49
Inventory Turnover	6.78

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.04% in the last 52 weeks. The beta is 0.40, so Kwang Dong Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-26.04%
50-Day Moving Average	5,581.80
200-Day Moving Average	6,344.40
Relative Strength Index (RSI)	57.34
Average Volume (20 Days)	82,897

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kwang Dong Pharmaceutical had revenue of KRW 1.63 trillion and earned 33.87 billion in profits. Earnings per share was 844.84.

Revenue	1.63T
Gross Profit	296.60B
Operating Income	26.70B
Pretax Income	51.60B
Net Income	33.87B
EBITDA	40.27B
EBIT	26.70B
Earnings Per Share (EPS)	844.84

Full Income Statement

Balance Sheet

The company has 218.26 billion in cash and 292.33 billion in debt, giving a net cash position of -74.07 billion or -1,847.91 per share.

Cash & Cash Equivalents	218.26B
Total Debt	292.33B
Net Cash	-74.07B
Net Cash Per Share	-1,847.91
Equity (Book Value)	616.67B
Book Value Per Share	14,311.99
Working Capital	207.96B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.41 billion and capital expenditures -64.63 billion, giving a free cash flow of -76.04 billion.

Operating Cash Flow	-11.41B
Capital Expenditures	-64.63B
Free Cash Flow	-76.04B
FCF Per Share	-1,897.27

Full Cash Flow Statement

Margins

Gross margin is 18.15%, with operating and profit margins of 1.63% and 2.07%.

Gross Margin	18.15%
Operating Margin	1.63%
Pretax Margin	3.16%
Profit Margin	2.07%
EBITDA Margin	2.46%
EBIT Margin	1.63%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 1.75%.

Dividend Per Share	100.00
Dividend Yield	1.75%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	11.83%
Buyback Yield	1.58%
Shareholder Yield	3.33%
Earnings Yield	14.82%
FCF Yield	-33.29%

Dividend Details

Stock Splits

The last stock split was on April 26, 1999. It was a forward split with a ratio of 5.

Last Split Date	Apr 26, 1999
Split Type	Forward
Split Ratio	5

Scores

Kwang Dong Pharmaceutical has an Altman Z-Score of 2.56. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.56
Piotroski F-Score	n/a